Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.

NCT00770133 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Ketotifen/naphazoline
DRUG: Naphazoline
DRUG: Ketotifen
DRUG: Vehicle

Sponsor

Bausch & Lomb Incorporated